Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
.png)
CHINA STARCH (03838) spent 630,300 Hong Kong dollars on June 2nd to repurchase 3.75 million shares.
FUJIKON IND(00927) issues profit warning, expected annual shareholder's loss of approximately HK$23.3 million to HK$29 million.
Intensive delivery of new cars ignites sales volume, with NIO (09866) soaring 62% year-on-year in May, boosting Hong Kong stocks by over 8%.
CHINA STARCH (03838) spent 630,300 Hong Kong dollars on June 2nd to repurchase 3.75 million shares.
FUJIKON IND(00927) issues profit warning, expected annual shareholder's loss of approximately HK$23.3 million to HK$29 million.
Intensive delivery of new cars ignites sales volume, with NIO (09866) soaring 62% year-on-year in May, boosting Hong Kong stocks by over 8%.
